ZYDUSLIFENSEZydus Lifesciences LimitedLowNeutral
Announced Wed, 13 May · 11:13 IST

Zydus Lifesciences Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+7.0%1-day move
₹928.60
prior close
₹932.25
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.2-0.1+0.0+7.0+8.5+6.8+9.6+12.0+11.8+16.7+17.1+21.8
Up moveDown movePending
AI summary

Zydus Lifesciences will declare its Q4 FY26 (January-March 2026) financial results on Tuesday, May 19, 2026. A post-results earnings Q&A session via webinar has been scheduled for the same day at 4:00 PM IST, which will be hosted by Dr. Sharvil Patel, Managing Director. The earnings presentation will be uploaded on the company's InvestorZone website after the results are announced. The audio recording and transcript of the call will also be made available on the company website, in compliance with SEBI listing regulations. This is a standard regulatory intimation filed under SEBI (LODR) Regulations.

Likely market impact

Shareholders should mark May 19, 2026 for Q4 FY26 results. The earnings call offers an opportunity to hear management's perspective on quarterly performance and ask questions directly to the Managing Director.